Education
About Us
Working with TipRanks
Follow Us
Novavax (NVAX)
NASDAQ:NVAX
Nvx-Cov2705
Covid-19, Sars-Cov-2 Infection
Phase IV
Not Yet Recruiting
Efficacy and Safety of NVX-CoV2705
Jul 17, 2025
―
Nvx-Cov2705
Covid-19, Sars-Cov-2 Infection
Phase III
Not Yet Recruiting
Safety and Immunogenicity of NVX-CoV2705
Jul 14, 2025
―
Protein Subunit: Novavax Covid-19 Vaccine, Pfizer Mrna Covid-19 Vaccine
Covid-19, Sars Cov 2 Infection, Vaccine-Preventable Diseases
Phase IV
Active Not Recruiting
Impact of Reactogenicity of the 2024-2025 COVID-19 Vaccines on Health Care Workers and First Responders in the United States
Oct 04, 2024
―
Coformulated Cic Vaccine, Fluzone Hd Trivalent
Influenza, Covid-19
Phase II/III
Withdrawn
Lot Consistency Study of COVID-19 and Influenza Combination Vaccine
Jun 27, 2024
―
Tniv 1 And Matrix-M Adjuvant
Covid-19
Phase II/III
Withdrawn
Phase 3 Lot Consistency Study of Trivalent Hemagglutinin Nanoparticle Influenza Vaccine
Jun 27, 2024
―
Nvx-Cov2705 Vaccine
Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Phase III
Completed
A Strain Change Study for SARS-CoV-2 rS Vaccines
May 08, 2024
―
Cic Vaccine Co-Formulated Tniv2 , Sarscov-2 Rs And Matrix-M Adjuvant, Novavax Covid-19 Vaccine, Tniv Vaccine, Fluzone High Dose
Covid-19
Phase III
Active Not Recruiting
A Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine and Influenza Combination Vaccine
Mar 01, 2024
―
Nvx-Cov2601 Co-Formulated Omicron Xbb.1.5 Sars-Cov-2 Rs Vaccine, Prototype/Xbb.1.5 Bivalent Vaccine (5 Μg)
Covid-19
Phase III
Completed
Phase 3 Adolescent Study for SARS-CoV-2 rS Variant Vaccines
Jul 31, 2023
―
Xbb.1.5 Vaccine (Booster), Xbb.1.5 Vaccine (Single Dose)
Covid-19
Phase II/III
Completed
A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants.
Jul 28, 2023
―
Nvx-Cov2373 (5Μg), Nvx-Cov2601 (5Μg), Nvx-Cov2601(5Μg), Nvx-Cov2601 (35Μg), Nvx-Cov2601(35Μg), Nvx-Cov2601(50Μg), Bivalent Ba.4/5
Covid-19
Phase II/III
Completed
Phase 2/3 Heterologous Boosting Study With Different Dose Levels of Monovalent SARS-CoV-2 rS Vaccines
Jun 27, 2023
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Novavax (NVAX) have in its pipeline
NVAX is currently developing the following drugs: Nvx-Cov2705, Nvx-Cov2705, Protein Subunit: Novavax Covid-19 Vaccine, Pfizer Mrna Covid-19 Vaccine. These drug candidates are in various stages of clinical development as the company works toward FDA approval.